Twice-weekly topical calcipotriene betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial).


Les auteurs

Lebwohl, M., Kircik, L. H., Lacour, J., Liljedahl, M., Lynde, C., Mørch, M. H., Papp, K. A., Perrot, J., Gold, L. S., Takhar, A., Thaçi, D., Warren, R. B., & Wollenberg, A.

LIre cette publication

Dans Journal of the American Academy of Dermatology, 84(5), 1269‑1277.
Scroll to Top